Valted Seq is a discovery stage biopharmaceutical company that utilizes big data to develop lifesaving therapeutics.
Valted Seq has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Valted Seq's investors include Octave Ventures LLC, DongKoo Bio&Pharma, OV Principal Investments.
Valted Seq is headquartered in Gaithersburg, United States.
Valted Seq is a discovery stage biopharmaceutical company that utilizes big data to develop lifesaving therapeutics.
Valted Seq is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Valted Seq — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/valted-seq. Accessed September 30, 2026.
VCBacked. (2021). Valted Seq — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/valted-seq
{{cite web |title=Valted Seq — Funding & Investors |url=https://www.vcbacked.co/company/valted-seq |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated